Trials / Completed
CompletedNCT00150280
Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery
A Prospective, Randomized, Double-Blind, Double-Dummy, Multi-Center Study Comparing Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 132 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To validate the analgesic efficacy and safety of celecoxib compared with ibuprofen SR in the management of acute pain post orthopedic or gynecological surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | celecoxib and ibuprofen SR |
Timeline
- Start date
- 2004-10-01
- Completion
- 2005-07-01
- First posted
- 2005-09-08
- Last updated
- 2021-03-03
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00150280. Inclusion in this directory is not an endorsement.